|
Characteristics
|
International cohort (N = 68)
|
Shanghai cohort (N = 47)
|
NCC cohort (N = 150)
|
|---|
|
Age, years
|
|
< 60
|
16 (23.53%)
|
26 (55.32%)
|
81 (54.00%)
|
|
≥ 60
|
52 (76.47%)
|
21 (44.68%)
|
69 (46.00%)
|
|
Sex
|
|
Male
|
48 (70.59%)
|
42 (89.36%)
|
119 (79.33%)
|
|
Female
|
20 (29.41%)
|
5 (10.64%)
|
31 (20.67%)
|
|
Smoking history
|
|
Yes
|
64 (94.12%)
|
32 (68.09%)
|
94 (62.67%)
|
|
No
|
3 (4.41%)
|
15 (31.91%)
|
56 (37.33%)
|
|
NA
|
1 (1.47%)
|
0 (0.00%)
|
0 (0.00%)
|
|
SCLC staging
|
|
I
|
33 (48.53%)
|
8 (17.02%)
|
49 (32.67%)
|
|
II
|
14 (20.59%)
|
39 (17.02%)
|
50 (33.33%)
|
|
III
|
21 (30.88%)
|
31 (65.96%)
|
51 (34.00%)
|
|
OS state
|
|
Alive
|
28 (41.18%)
|
24 (51.06%)
|
69 (46.00%)
|
|
Death
|
40 (58.82%)
|
23 (48.94%)
|
81 (54.00%)
|
- Data are n (%).
- NCC, National Cancer Center; NA, not available; SCLC, small cell lung cancer; OS, overall survival
